1
Hans Leysieffer, Hans Peter Zenner, Joachim W Baumann: At least partially implantable system for rehabilitation of hearing disorder. Cochlear, David S Safran, Nixon Peabody, May 20, 2003: US06565503 (109 worldwide citation)

An at least partially implantable system for rehabilitation of a hearing disorder with at least one acoustic sensor (microphone) for picking up an acoustic sensor signal and converting the acoustic sensor signal into corresponding electrical signals, an electronic signal processing unit for audio si ...


2
Hans Peter Zenner, J Peter Ruppersberg, Andreas Busch: Method for treating diseases of the inner ear using adamantane derivatives. Tinnitus Forschungs und Entwicklungs, Pennie & Edmonds, May 23, 2000: US06066652 (27 worldwide citation)

Use of adamantane derivatives of the formula ##STR1## in which R1 and R2 are identical or different and can be hydrogen or straight-chained or branched alkyl groups having 1 to 6 carbon atoms, or


3
Hans Peter Zenner, Rolf Lehner: Implantable dosaging system. Eckert Seamans Cherin & Mellott, April 20, 1999: US05895372 (9 worldwide citation)

An implantable dosaging system for medications, active substances, etc. administered in the form of dissolved or suspended fluids having a medication reservoir, a pump for administering the medication, an actuator for the transcutaneous operation of the pump, a self-sealing port, particularly for re ...


4
Hans Peter Zenner, Anthony W Gummer: Determination of data concerning a persons auditory capacity. Pennie & Edmonds, December 28, 1999: US06007494 (8 worldwide citation)

The invention concerns a device for determining data on auditory capacity, the device having preferably non-contact means for measuring vibrations of the middle-ear ossicles (22, 23, 24) and/or the tympanic membrane (21) by means of electromagnetic waves. The electromagnetic waves used for the measu ...


5
Hans Leysieffer, Hans Peter Zenner: Process for optimization of mechanical inner ear stimulation in partially or fully implantable hearing systems. IMPLEX Aktiengesellschaft Hearing Technology, David S Safran, Nixon Peabody, September 5, 2000: US06113531 (5 worldwide citation)

In a process for optimization of mechanical inner ear stimulation in an at least partially implantable hearing system for rehabilitation of a hearing impairment with an electromechanical converter which transmits its output-side mechanical vibrational energy via mechanical stimulation of a middle ea ...


6
Erich Goll, Ernst Dalhoff, Hans Peter Zenner: Hearing aid and method for eliminating acoustic feedback in the amplification of acoustic signals. Eberhard Karls Universitaet Tuebingen Universitaetsklinikum, Morrison & Foerster, July 7, 2015: US09078073

In a hearing aid having a microphone to be arranged at a body of a user for capturing ambient sound, a loudspeaker for outputting the ambient sound after having been amplified on a frequency-dependent basis, and a signal processor, the signal processor is configured to amplify the sound such that th ...


7
Hans Leysieffer, Hans Peter Zenner, Joachim W Baumann: At least partially implantable system for rehabilitation of hearing disorder. Nixon Peabody, December 6, 2001: US20010049466-A1

An at least partially implantable system for rehabilitation of a hearing disorder with at least one acoustic sensor (microphone) for picking up an acoustic sensor signal and converting the acoustic sensor signal into corresponding electrical signals, an electronic signal processing unit for audio si ...


8
Hans Peter Zenner, J P Ruppersberg, A Busch: Use of adamantan derivatives for treating diseases of inner ear. Tianlitus Research And Development, wang jingchao, September 30, 1998: CN96196650

The invention concerns the use of adamantane derivatives of formula (I), in which R1 and R2 are identical or different and can be hydrogen or straight-chained or branched alkyl groups with between 1 and 6 carbon atoms, or, together with the nitrogen atom, can be a heterocyclic group with 5 or 6 ring ...


9
Christian Simon, Hans Peter Zenner: Use of matrix metalloprotease inhibitors for the treatment of cancer. Nath & Associates, April 8, 2004: US20040067883-A1

The invention relates to the use of an active agent, particularly an inhibitor, in treating cancer by influencing, preferably inhibiting the expression of matrix-metalloproteases. The targets for this active agent can especially related to downstream regulators of the matrix-metalloprotease 9 (MMP-9 ...


10
Christian Simon, Hans Peter Zenner: Use of matrix metalloprotease ihibitors for treatment of cancer. Christian Simon, November 26, 2003: CN01815690

The invention relates to the use of an active agent, particularly an inhibitor, in treating cancer by influencing, preferably inhibiting the expression of matrix-metalloproteases. The targets for this active agent can especially related to downstream regulators of the matrix-metalloprotease 9 (MMP-9 ...



Click the thumbnails below to visualize the patent trend.